Ipamorelin/Tesamorelin Blend 13mg
Entry Ipamorelin/Tesamorelin Stack for GH and Fat Loss Research
Combines 3mg Ipamorelin with 10mg Tesamorelin to pair GHRP selectivity with the FDA-validated GHRH for GH restoration and visceral fat reduction research.
Entry Ipamorelin/Tesamorelin Stack for GH and Fat Loss Research
Tesamorelin-dominant blend pairing FDA-approved GHRH visceral fat reduction activity with Ipamorelin's clean GH pulse amplification for synergistic GH/IGF-1 and metabolic research.
As one of the most studied compounds in the bundles & stacks research space, Ipa/Tesa 13mg has attracted sustained scientific interest across Visceral fat and GH research, Combined GHRH+GHRP studies. Peer-reviewed evidence indicates that fDA-validated Tesamorelin mechanism + Ipamorelin amplification, which has positioned Ipa/Tesa 13mg as a reference standard for researchers exploring visceral fat and gh research outcomes. The compound's selectivity and documented tolerability in preclinical models have contributed to a rapidly growing body of literature over the past decade.
Ipa/Tesa 13mg Documented Benefits: 2 Documented Mechanisms
Visceral Fat Research
Tesamorelin-dominant formulation targets the FDA-validated visceral fat reduction mechanism.
GH Amplification
Ipamorelin amplifies GH pulses via complementary GHS-R1a activation.
How Ipa/Tesa 13mg Works: Molecular Mechanism & Pathway
Tesamorelin GHRH-R activation for sustained GH elevation + Ipamorelin GHS-R1a agonism for enhanced GH pulse amplitude.
The 2 primary research pathways identified for Ipa/Tesa 13mg — Visceral Fat Research, GH Amplification — collectively point to a compound with pleiotropic activity across interconnected biological systems. Studies have further shown that visceral fat + GH axis dual research, reinforcing the mechanistic picture established in earlier cell-line work. Unlike single-pathway agents, Ipa/Tesa 13mg's broad receptor engagement profile continues to generate hypotheses for novel applications beyond its originally characterized use cases.
Research Protocols & Compound Combinations
Ipa/Tesa 13mg is routinely studied alongside Tesamorelin and Ipa/CJC Blend in bundles & stacks-focused compound panels. Researchers investigating visceral fat and gh research have found that pairing compounds with complementary receptor profiles can produce additive results while keeping individual doses within well-characterized ranges. Preliminary evidence that 99%+ purity has informed several of these multi-compound protocol designs.
Purity, Testing & Research Grade Standards
All Ipa/Tesa 13mg research material offered through this catalog is manufactured under controlled conditions and independently verified by a third-party laboratory prior to release. Each lot undergoes High-Performance Liquid Chromatography (HPLC) analysis to confirm ≥98% purity, with identity confirmed via mass spectrometry. The accompanying Certificate of Analysis (CoA) documents the exact purity, molecular weight confirmation, and lot-specific testing date — data that should accompany any reproducible research protocol. Lyophilized powder formulation ensures maximum stability during shipping and storage at −20°C long-term or 4°C for short-term use.
◈ Key Highlights
- FDA-validated Tesamorelin mechanism + Ipamorelin amplification
- Visceral fat + GH axis dual research
- 99%+ purity
Ideal For
- Visceral fat and GH research
- Combined GHRH+GHRP studies
Intended for laboratory use only. Not for human or animal consumption. Not FDA approved. Handle in appropriate lab settings only.
What the Research Shows
The following data points are derived from peer-reviewed preclinical and clinical studies on Ipa/Tesa 13mg. All studies cited in compound profiles are indexed in PubMed or published in peer-reviewed journals.
FDA-validated Tesamorelin mechanism + Ipamorelin amplification
Visceral fat + GH axis dual research
99%+ purity
Third-Party Verified Every Batch
Each vial of Ipa/Tesa 13mg is independently tested by a third-party laboratory before fulfillment. You receive the actual CoA (Certificate of Analysis) documentation with your order.
